China's Top Departments: Gastroenterology at Huashan Hospital, Fudan University
Established in 1964 and a National Clinical Key Specialty, Huashan Hospital's Gastroenterology Department is a leader in digestive tumor immunotherapy, innovative endoscopic techniques, and complex digestive disease care. Here's what international patients should know about its four subspecialties.
What matters most on this page
Short answer:Established in 1964 and a National Clinical Key Specialty, Huashan Hospital's Gastroenterology Department is a leader in digestive tumor immunotherapy, innovative endoscopic techniques, and complex digestive disease care. Here's what international patients should know about its four subspecialties.
Key points
- National Clinical Key Specialty (since 2012)
- Fudan University Institute of Digestive Diseases
- 4 Subspecialties: Oncology, Endoscopy, IBD, Fatty Liver
- ~200 Papers in Cell, Cancer Cell, JCI, The Lancet
If you or a loved one is facing a digestive disease — especially a digestive tumor, inflammatory bowel disease (IBD), fatty liver, or a complex condition requiring advanced endoscopy — the Department of Gastroenterology at Huashan Hospital is among the most experienced centers in China.
Established in 1964, the department is a National Clinical Key Specialty and the home of the Fudan University Institute of Digestive Diseases. It holds a leading position in personalized immunotherapy for digestive tumors, innovative endoscopic techniques, and the diagnosis and treatment of complex and rare digestive diseases.
The department has 35 team members, including 19 full/associate professors and 8 doctoral/master supervisors, with a postdoctoral research station. Under the leadership of Chair Professor Liu Jie, it combines clinical excellence with cutting-edge research.
At Medora, we've helped international patients navigate Huashan's gastroenterology department. Here's what you need to know.
Accreditations & Rankings
| Recognition | Issuing Body |
|---|---|
| National Clinical Key Specialty | Ministry of Health (2012) |
| Fudan University Institute of Digestive Diseases | Fudan University |
| NSFC Innovative Research Group | National Natural Science Foundation of China (2021) |
| Shanghai High-Level University Innovation Team | Shanghai Municipal Government (2019) |
| Shanghai Intelligent Tumor Drug Engineering Technology Research Center | Shanghai (2019) |
| Small Bowel Endoscopy Training Center | Chinese Medical Doctor Association (2017) |
| Shanghai Clinical Key Specialty Take-off Plan (2 grants) | Shanghai Municipal Government (2018) |
| Institute of Immunophenomics, Shanghai International Human Phenome Institute | Fudan University (2020) |
Expert Team
The department is chaired by Professor Liu Jie, one of China's most decorated gastroenterologists.
Chair & Academic Leader: Professor Liu Jie
- NSFC Innovative Research Group Leader
- Changjiang Scholar Distinguished Professor, Ministry of Education
- National Outstanding Youth Science Fund Recipient
- National Hundred-Thousand-Ten-Thousand Talent Project
- Chief Scientist, National Key R&D Program
- Fudan University Distinguished Professor, Shanghai Leading Talent
Deputy Directors: Liu Yi, Ding Weiqun, Sun Xu, Luo Zhongguang, Luo Feifei
National-Level Talent Roster:
- 1 NSFC Innovative Research Group Leader
- 1 National Outstanding Youth Science Fund Recipient
- 1 Changjiang Scholar Distinguished Professor
- 1 National Young Top-Notch Talent
- 1 National Hundred-Thousand-Ten-Thousand Talent
- 1 Ministry of Education New Century Excellent Talent
- 1 Sackler Chinese Physician of the Year Awardee
Multiple Shanghai-level talents including Shanghai Leading Talent, Outstanding Discipline Leader, Shuguang Scholar, and Rising Star.
Four Subspecialties
1. Digestive Oncology
Focused on comprehensive treatment of esophageal, gastric, colorectal, liver, pancreatic, and gallbladder cancers.
Core Innovations:
- Immune-Adaptive Chemotherapy: Reduced toxicity, sustained tumor killing, and preserved immune function
- Endoscopic Cryoballoon Ablation for Gastric Cancer (ECAT): A pioneering technique that destroys tumor cells while releasing antigens to activate anti-tumor immunity — enabling organ preservation in select elderly patients
2. Digestive Endoscopy
A full-spectrum endoscopic service from routine to ultra-minimally invasive:
- Standard: Magnification endoscopy, EMR, ESD
- Advanced: ESE, EFTR, STER, POEM, ERCP, EUS-FNA
- Cutting-edge: SpyGlass cholangioscopy, Confocal Laser Endomicroscopy (CLE), Double-Balloon Enteroscopy (DBE)
🏆 Special Strength — Small Intestinal Diseases The team performs 200+ enteroscopy cases annually, accurately diagnosing inflammatory bowel disease, CMUSE, Peutz-Jeghers syndrome, primary intestinal lymphangiectasia, intestinal amyloidosis, intestinal lymphoma, and more.
3. Inflammatory Bowel Disease (IBD)
Seeing 3,000+ patient visits annually, covering the full treatment cycle:
- Endoscopic diagnosis (capsule endoscopy, DBE)
- Non-invasive imaging (small bowel MR/CT)
- Pharmacotherapy (novel biologics, small-molecule oral drugs, therapeutic drug monitoring)
- Personalized treatment, health education, dietary guidance
- Active participation in clinical trials
4. Fatty Liver & Liver Dysfunction
Specializing in fatty liver disease, drug-induced hepatitis, and autoimmune liver disease.
- "Gut-Liver Synergy" treatment approach
- Obesity-Fatty Liver joint clinic (with Endocrinology)
- Obesity MDT clinic (with Bariatric Surgery & Endocrinology)
- FibroTouch non-invasive quantitative assessment of steatosis and fibrosis
Research Excellence
The department leads multiple national-level projects including NSFC Innovative Research Groups, National Key R&D Programs, and Key NSFC Projects. It has published nearly 200 papers in top journals such as Cell, Cancer Cell, Cell Metabolism, JCI, PNAS, and The Lancet, and holds 20+ national invention patents. Awards include the Chinese Medical Science and Technology Award and Shanghai Medical Science and Technology Award.
Highlight Innovations:
- 5hmC hydroxymethylation-based non-invasive tumor diagnostic method
- Novel secretory BiTE-T therapy overcoming solid tumor immune cell therapy barriers
- Biomimetic cell membrane ginsenoside tumor-targeted drug delivery and immune activation platform
- Immune index-guided tumor treatment paradigm based on immune homeostasis
Milestones
| Year | Honor |
|---|---|
| 2012 | National Clinical Key Specialty (Ministry of Health) |
| 2017 | Small Bowel Endoscopy Training Center (Chinese Medical Doctor Association) |
| 2018 | Shanghai Clinical Key Specialty Take-off Plan (2 grants) |
| 2019 | Shanghai High-Level University Innovation Team |
| 2019 | Shanghai Intelligent Tumor Drug Engineering Technology Research Center |
| 2020 | Institute of Immunophenomics, Shanghai International Human Phenome Institute |
| 2021 | NSFC Innovative Research Group |
| 2021 | Fudan University Institute for Interdisciplinary Research in Immune Disease |
Location
Huashan Hospital, Fudan University 12 Wulumuqi Middle Road, Jing'an District, Shanghai, China
This guide is prepared for an international audience. If you need assistance with medical consultation, appointment booking, or travel arrangements to Huashan Hospital's Gastroenterology Department, contact Medora for personalized support.
Need personalized hospital recommendations?
Turn this research into an action plan: get tailored hospital recommendations matched to your condition, budget, and timeline.
✓ Free consultation · Response within 24 hours · 100+ international patients served